GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Shandong Bailong Chuangyuan Bio-Tech Co Ltd (SHSE:605016) » Definitions » Total Assets

Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) Total Assets : ¥1,927 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shandong Bailong Chuangyuan Bio-Tech Co Total Assets?

Shandong Bailong Chuangyuan Bio-Tech Co's Total Assets for the quarter that ended in Sep. 2024 was ¥1,927 Mil.

Warning Sign:

If a company builds assets at 17.6% a year, faster than its revenue growth rate of 12.7% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Shandong Bailong Chuangyuan Bio-Tech Co's average Total Assets Growth Rate was 30.80% per year. During the past 3 years, the average Total Assets Growth Rate was 24.00% per year. During the past 5 years, the average Total Assets Growth Rate was 17.60% per year.

During the past 8 years, Shandong Bailong Chuangyuan Bio-Tech Co's highest 3-Year average Total Assets Growth Rate was 24.00%. The lowest was 11.10%. And the median was 12.90%.

Total Assets is connected with ROA %. Shandong Bailong Chuangyuan Bio-Tech Co's annualized ROA % for the quarter that ended in Sep. 2024 was 13.16%. Total Assets is also linked to Revenue through Asset Turnover. Shandong Bailong Chuangyuan Bio-Tech Co's Asset Turnover for the quarter that ended in Sep. 2024 was 0.15.


Shandong Bailong Chuangyuan Bio-Tech Co Total Assets Historical Data

The historical data trend for Shandong Bailong Chuangyuan Bio-Tech Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Bailong Chuangyuan Bio-Tech Co Total Assets Chart

Shandong Bailong Chuangyuan Bio-Tech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial 754.35 836.00 1,282.51 1,471.95 1,754.18

Shandong Bailong Chuangyuan Bio-Tech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,654.56 1,754.18 1,886.31 1,903.17 1,927.38

Shandong Bailong Chuangyuan Bio-Tech Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Shandong Bailong Chuangyuan Bio-Tech Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=1507.828+246.352
=1,754

Shandong Bailong Chuangyuan Bio-Tech Co's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets=Total Equity (Q: Sep. 2024 )+Total Liabilities (Q: Sep. 2024 )
=1621.08+306.302
=1,927

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Bailong Chuangyuan Bio-Tech Co  (SHSE:605016) Total Assets Explanation

Total Assets is connected with ROA %.

Shandong Bailong Chuangyuan Bio-Tech Co's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=252.116/( (1903.166+1927.381)/ 2 )
=252.116/1915.2735
=13.16 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Shandong Bailong Chuangyuan Bio-Tech Co's Asset Turnover for the quarter that ended in Sep. 2024 is

Asset Turnover
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=289.039/( (1903.166+1927.381)/ 2 )
=289.039/1915.2735
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Shandong Bailong Chuangyuan Bio-Tech Co Total Assets Related Terms

Thank you for viewing the detailed overview of Shandong Bailong Chuangyuan Bio-Tech Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Bailong Chuangyuan Bio-Tech Co Business Description

Traded in Other Exchanges
N/A
Address
Dexin Street, National High-tech Industrial Development Zone, Yucheng, Shandong Province, Dezhou, CHN, 251200
Shandong Bailong Chuangyuan Bio-Tech Co Ltd is engaged in the research and development, production and sales of prebiotic series products, dietary fiber series products, other starch sugar (alcohol) series products and healthy sweetener products.
Executives
Zhao De Xuan senior management
Dou Bao De Director
An Lian Lian Director
Zhang An Guo Director

Shandong Bailong Chuangyuan Bio-Tech Co Headlines

No Headlines